Please login to the form below

Not currently logged in

Merck sees €85.9m loss for Q2

German pharmaceutical firm Merck KGaA has recorded a second quarter loss of €85.9m in its financial results for 2011 and has cut its profit forecast for the year

German pharmaceutical firm Merck KGaA (known as EMD Chemicals in the US and Canada) has recorded a second quarter loss of €85.9m in its financial results for 2011 and has cut its profit forecast for the year.

Merck's performance was affected by one-time costs related to the company's acquisitions of Serono and Millipore.

The Millipore acquisition also contributed to greater operating expenses, which more than doubled in the second quarter of 2011 to €270m from €109m in 2010.

According to Merck's chairman, Dr Karl-Ludwig Kley, these costs meant the company expected operating profit for 2011 to be around $1bn. In its Q1 report, the company said it was aiming for a 35-45 per cent rise on last year's €1.1bn profit.

Kley also suggested the company would begin cost cutting measures: "We are striving for leaner processes and we are reviewing our cost structures. Generating attractive returns on invested capital and cost management continue to be the top priorities on our agenda."

He continued: "The first steps have already been taken this year. These include the changes in the Merck Executive Board, in Merck Serono and Consumer Health Care as well as decisions resulting from our pipeline review."

27th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....